17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
When California’s AB 5 was signed into law last month, a chorus of voices decried the fact that it ...
Read More >
2019 was an interesting year, especially politically and legally. Yet Indonesia has made it to 2020 ...
Read More >
In Fischer v. Sentry Ins. A Mutual Co., an employee kept a log of when she felt sexually harassed or...
Read More >
So about those May jobs numbers . . . . The return of 2.5 million jobs in May was a welcome and larg...
Read More >
On June 11, 2019, Alabama Governor Kay Ivey signed into law the Clark-Figures Equal Pay Act (the “A...
Read More >
When a contractor delivers goods to the government that do not conform to the precise requirements o...
Read More >